XBiotech Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2014 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
XBiotech Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2014 to Q2 2024.
  • XBiotech Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$13M, a 48.8% decline year-over-year.
  • XBiotech Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$35M, a 23.2% decline year-over-year.
  • XBiotech Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$24.6M, a 25.4% increase from 2022.
  • XBiotech Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$32.9M, a 88.9% decline from 2021.
  • XBiotech Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$17.4M, a 55.2% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$35M -$13M -$4.26M -48.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 -$30.7M -$10M -$6.19M -162% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 -$24.6M -$4.64M -$1.43M -44.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-15
Q3 2023 -$23.1M -$7.36M +$5.29M +41.8% Jul 1, 2023 Sep 30, 2023 10-K 2024-03-15
Q2 2023 -$28.4M -$8.74M +$2.9M +24.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 -$31.3M -$3.82M +$1.58M +29.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 -$32.9M -$3.2M +$3.26M +50.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-15
Q3 2022 -$36.2M -$12.7M -$9.4M -288% Jul 1, 2022 Sep 30, 2022 10-K 2024-03-15
Q2 2022 -$26.8M -$11.6M -$6.53M -128% Apr 1, 2022 Jun 30, 2022 10-K 2024-03-15
Q1 2022 -$20.2M -$5.4M -$2.83M -110% Jan 1, 2022 Mar 31, 2022 10-K 2024-03-15
Q4 2021 -$17.4M -$6.47M -$4.63M -252% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-15
Q3 2021 -$12.8M -$3.26M -$735K -29.1% Jul 1, 2021 Sep 30, 2021 10-K 2023-03-15
Q2 2021 -$12.1M -$5.12M +$1.73M +25.2% Apr 1, 2021 Jun 30, 2021 10-K 2023-03-15
Q1 2021 -$13.8M -$2.57M -$2.55M Jan 1, 2021 Mar 31, 2021 10-K 2023-03-15
Q4 2020 -$11.2M -$1.84M -$688M -100% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-15
Q3 2020 $677M -$2.53M +$3.62M +58.9% Jul 1, 2020 Sep 30, 2020 10-K 2022-03-15
Q2 2020 $673M -$6.84M -$992K -17% Apr 1, 2020 Jun 30, 2020 10-K 2022-03-15
Q1 2020 $674M -$14K* +$5.85M Jan 1, 2020 Mar 31, 2020 10-K 2022-03-15
Q4 2019 $669M $686M +$693M Oct 1, 2019 Dec 31, 2019 10-K 2021-03-16
Q3 2019 -$24M -$6.15M -$1.1M -21.8% Jul 1, 2019 Sep 30, 2019 10-K 2021-03-16
Q2 2019 -$22.9M -$5.85M +$55K +0.93% Apr 1, 2019 Jun 30, 2019 10-K 2021-03-16
Q1 2019 -$22.9M -$5.86M -$1.8M -44.1% Jan 1, 2019 Mar 31, 2019 10-K 2021-03-16
Q4 2018 -$21.1M -$6.11M +$1.14M +15.7% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-16
Q3 2018 -$22.3M -$5.05M +$1.15M +18.6% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-16
Q2 2018 -$23.4M -$5.91M +$3.23M +35.3% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-16
Q1 2018 -$26.7M -$4.07M +$6.49M +61.5% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-16
Q4 2017 -$33.2M -$7.25M +$9.15M +55.8% Oct 1, 2017 Dec 31, 2017 10-K/A 2019-03-15
Q3 2017 -$42.3M -$6.21M +$6.28M +50.3% Jul 1, 2017 Sep 30, 2017 10-K/A 2019-03-15
Q2 2017 -$48.6M -$9.13M +$4.49M +33% Apr 1, 2017 Jun 30, 2017 10-K/A 2019-03-15
Q1 2017 -$53.1M -$10.6M -$306K -2.98% Jan 1, 2017 Mar 31, 2017 10-K/A 2019-03-15
Q4 2016 -$52.8M -$16.4M -$4.51M -37.9% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-16
Q3 2016 -$48.3M -$12.5M -$1.75M -16.3% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-16
Q2 2016 -$46.5M -$13.6M -$6.88M -102% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-16
Q1 2016 -$39.6M -$10.3M -$2.14M -26.4% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-16
Q4 2015 -$37.5M -$11.9M -$5.54M -87.2% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-16
Q3 2015 -$31.9M -$10.7M -$3.77M -54.2% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 -$28.2M -$6.74M -$2.84M -72.7% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-12
Q1 2015 -$25.3M -$8.11M -$3.61M -80.2% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-13
Q4 2014 -$21.7M -$6.35M Oct 1, 2014 Dec 31, 2014 10-K 2017-03-16
Q3 2014 -$6.96M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-13
Q2 2014 -$3.91M Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-14
Q1 2014 -$4.5M Jan 1, 2014 Mar 31, 2014 10-Q/A 2015-06-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.